Balaji Amines Limited — Investor Meet, 23-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Balaji Amines (#BALAMINES) delivered solid Q4 FY26 performance with ₹403 Cr revenue (up 12% YoY) and 25% EBITDA margin, driven by stable demand and operational efficiencies. Full-year FY26 revenue reached ₹1,454 Cr (up 2% YoY), with EBITDA up 11% to ₹294 Cr. Management anticipates 10-15% consolidated volume growth for FY27, powered by commissioning new projects like DME, NMM, Acetonitrile, and significant expansions at Balaji Specialty Chemicals. Strategic focus remains on high-value specialty chemicals and import substitution. The outlook is positive, emphasizing project execution and scaling new products.